The luciferase reporter gene is a useful tool for determining the efficacy of transfection of plasmid DNA and adenovirusmediated gene transfer in vivo. However, we report here that the haemoglobin present in tissue samples can mask the detection of the luciferase activity and lead to underestimation of the luciferase levels. We evaluated the degree of interference in different organ samples of mice and investigated the possibilities for removal of haemoglobin from tissue samples by: (1) perfusion of the whole animal; (2) dif-
Luminescent reporter gene assays for luciferase are frequently employed to determine the efficiency of gene transfer in vitro, as they allow quantitative evaluation of luciferase gene expression after transfection. Numerous studies in vivo have used this assay to analyse the gene transfer efficacy of plasmid DNA by different liposome preparations in vivo [1] [2] [3] [4] [5] [6] [7] and some investigations have also examined the efficacy of transduction by adenoviral vectors carrying the luciferase gene after administration to mice by different routes. 8, 9 . After performing successful nonviral integrinmediated gene transfer by an RGD-oligolysine vector using a luciferase reporter gene in vitro [10] [11] [12] we started testing this vector system in vivo in mice. The extremely low levels of luciferase activity in these experiments and similar reports in the literature [1] [2] [3] [4] [5] [6] led us to question the sensitivity of detection of luciferase activity by the assay generally employed for animal tissues and to investigate possible factors that may interfere with the luciferase assay, in particular whole blood.
In initial model experiments we added different amounts of whole mouse blood, haemoglobin or plasma to a constant amount of lysed tracheal cells expressing a luciferase reporter gene, and evaluated the luciferase activity by luminometry. Both whole blood and haemoglobin, the latter at a concentration approximately equiv- alent to that of whole mouse blood led to a similar decrease in the detected luminescence ( Figure 1 ). Neither plasma (blood collected in the presence of EDTA thus containing coagulation factors) ( Figure 1 ) nor serum (clotted blood devoid of coagulation factors) (data not shown), added in the same volumes as whole blood, resulted in a significant decrease in the relative light units (RLU). Addition of lysate buffer instead of blood or haemoglobin did not modify the control value (data not shown). These results indicate that it is the haemoglobin in the blood which interferes with the assay and suggest that haemoglobin contamination results in a considerable decrease in the detectable luciferase activity.
Theoretically it may be possible to calculate the degree of interference if the haemoglobin content of the different organs is known. We therefore estimated the haemoglobin content of organ samples by colorimetry using Drabkin's reagent. The degree of interference could then be determined based on the data shown in Figure 1 . It was highest for the lung and slightly lower for both the liver and the spleen (Figure 2 ). Chloroform extraction before analysis was required to remove lipid which interfered with the colorimetric estimations. During this procedure some loss of haemoglobin occurred, which may have resulted in a slight underestimation of the amount of haemoglobin.
Having established that haemoglobin interferes with the assay, we hypothesised that dilution of the samples may reveal a greater amount of luciferase activity. Indeed, a dilution factor of 10 for the liver and spleen homogenates led to a seven-and 2.8-fold increase in detectable luciferase activity, respectively, and a dilution factor of four for the lung led to a 1.7-fold increase ( Figure 3 ). Although the emission spectrum of firefly luciferase peaks at 562 nm (SWISS-PROT entry LUCI PHOPY), it ranges from 510 to 650. 13 The major peak of haemoglobin light absorption occures at 408 nm, as indicated above for haemoglobin quantification. However, haemoglobin exists in several different forms (O 2 Hb, COHb, HHb and MetHb) each of which has different absorbance spectra. We examined the light absorbance spectra of the different mice organ homogenates, haemoglobin and mice whole blood to determine the degree of overlap with the emission spectrum of luciferase (Figure 4) . Substantial absorbance at the peak values of 575 and 540 nm was observed in diluted homogenates. Thus these forms of haemoglobin are probably responsible for the interference since they overlap with the luciferase spectrum.
Next therefore, we sought to remove haemoglobin from the tissue samples before determination of the luciferase activity. Three different approaches were investigated: (1) transcardiac perfusion of mice with an isotonic buffer; (2) preferential lysis of red blood cells
Figure 4 Visible absorption spectra of mouse organ homogenates. The spectra of liver (a) (1/375 dilution), lung (b) (1/125 dilution) and spleen (c) (1/125 dilution) homogenates and of mouse haemoglobin (d) (1.4 mg/ml) and mouse whole blood (e) (1/75 dilution) are presented. The bar
represents the range of the luciferase emission spectrum as described previously. 13 with hypotonic buffers; and (3) chromatographic separation of the luciferase protein from haemoglobin in homogenates.
Transcardiac perfusion was performed through the left and right ventricles and resulted in visible removal of blood from the liver and lungs. This is reflected in the decrease in the estimated haemoglobin content of these organs (Figure 5a and b) . Measurement of the optical density at 408 nm, the optimum wavelength for haemoglobin light absorption, is an easy and rapid method for determining the efficacity of the perfusion. The lung was the most efficiently perfused organ. This procedure also resulted in a substantial increase in the detectable luciferase activities, in particular for the liver (six-fold) and the lung (eight-fold) (Figure 5c ) while the spleen showed a lower increase (two-fold).
We then investigated two different hypotonic treatments allowing preferential lysis of red blood cells for removal of haemoglobin. Such techniques are used to remove erythrocytes from lymphocyte and spleen cell preparations.
14 To achieve this, tissues of mice injected with AdMLPLuc were diced very finely and incubated on ice for a short period in either: (1) PBS; or (2) a hypotonic Tris-HCl buffer containing either 5 mm MgCl 2 and 10 mm NaCl or 144 mm NH 4 Cl. The supernatant containing haemoglobin was removed and the remaining pellet was washed twice before lysis and assay for luciferase activity. This hypotonic treatment resulted in a slight increase in the detected luciferase activity in the liver (1.3-fold), but also in reduced activity in the spleen and lung samples which may be due to the loss of some luciferase activity during hypotonic treatment.
The separation of the luciferase protein from haemoglobin was also attempted by other techniques including ammonium sulphate precipitation and chromatography. Firefly luciferase has been reported to salt-out at 50 to 60% (NH 4 ) 2 SO 4 , 13 while haemoglobin precipitates at 85%. 15 However, when an aliquot of tissue homogenates in lysis buffer was brought to 60% (NH 4 ) 2 SO 4 the precipitate still contained some haemoglobin, and in the case of the liver it was no longer soluble in lysis buffer. As firefly Gene Therapy luciferase has a lower pI than haemoglobin ion-exchange chromatography was also tested but, unfortunately, substantial separation was not achieved. In addition, high salt concentrations (200 mm MgCl 2 ) were required to elute the luciferase from the anion exchanger and we noted that the luminescence reaction was sensitive to the salt concentration. Since haemoglobin contains twice as many histidine residues as luciferase we also tested immobilized metal affinity resines usually used for purification of histidine-tagged proteins. However, we were unable to separate the two proteins satisfactorily even by elution with imidazol which competes with histidine for binding. Thus all these alternative techniques investigated appear less efficient than transcardiac perfusion.
The observed decrease in the detectable luciferase activity in the presence of haemoglobin is most likely due to quenching of the luminescence that is emitted by the reaction of luciferase with its substrate d-luciferin, rather than to direct inhibition of the luciferase activity by haemoglobin. This is suggested by the increase in the detectable luciferase activity after dilution of organ homogenates which decreases the absorption at wavelengths corresponding to the emission peak of luciferase (562 nm; yellow-green). However, direct interaction between the two proteins can not be excluded.
There exists several luciferases other than the North American firefly luciferase used in the present study. Each has a different emission maxima: the North American firefly, Photinus pyralis (LUCI PHOPY); Japanese firefly, Luciola cruciata (LUCI LUCCR); the sea pansy, Renilia reniformis (LUCI RENRE); the sea firefly, Vargula hilgendorfii (LUCI VARHI) have lambda max at 562, 544, 480 and 460 nm, respectively. Detection of the activity of all these enzymes would be reduced in the presence of haemoglobin. However, mutant Japanese firefly luciferase producing orange (lambda max, 607 nm) and red light (lambda max, 609 and 612 nm) have been reported and thus their emission should not be quenched by haemoglobin, 17 though the detector used would also be required to detect in the red. The spectral sensitivity of the photomultiplier of the luminometer used in this study covers a range between 390 and 620 nm with greatest sensitivity in the blue range. This instrumentation is also the most frequently used by most investigators interested in evaluating gene transfer. In addition, other broad spectrum detectors used in low light detection such as charge coupled devices (CCD) cameras may compensate for some of the effect of hemoglobin on yellow-green luciferase detection.
Nonetheless our results indicate that it is advisable to remove a maximum amount of haemoglobin when performing quantitative analysis of luciferase activity in organs. The perfusion of the whole animal appears to be an effective procedure for removal of haemoglobin from organs. We were particularly interested in the lung and therefore chose to perform intracardiac perfusion. This has allowed us to establish the principle of perfusion as a technique of circumventing the interference of haemogolobin in the luciferase assay. However, perfusion of the liver is probably best performed directly through the portal vein.
In conclusion, our results suggest that luciferase activity levels in previous reports in vivo may have been underestimated due to the presence of blood.
